Biblio
Export 1465 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is H [Clear All Filters]
“Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1745-1750, 2022.
, “Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1745-1750, 2022.
, “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
, “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
, “A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.”, J Alzheimers Dis, vol. 89, no. 3, pp. 913-922, 2022.
, “A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.”, J Alzheimers Dis, vol. 89, no. 3, pp. 913-922, 2022.
, “Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.”, J Alzheimers Dis, vol. 88, no. 1, pp. 335-344, 2022.
, “Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.”, J Alzheimers Dis, vol. 88, no. 1, pp. 335-344, 2022.
, “Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
, “Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1329-1337, 2022.
, “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
, “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
, “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
, “Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.
, “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
, “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
, “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
, “Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
, “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
, “Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
, “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
,